About YJ BioTech
YJ. Biotechnology Co., Ltd., founded in March 2020, is headquartered in Linkou District, New Taipei City, Taiwan, with a dedicated R&D center. We are driven by core values of pragmatism, professionalism, and excellence in innovation, striving to apply Taiwan's leading medical and technological expertise to advance cutting-edge cell manufacturing technologies.
YJ Biotech holds 3 key technologies and over 12 exclusive patents. Our self-developed "YJ Isolator," a pharmaceutical isolation device, enables the creation of GMP-compliant micro-intelligent cell factories. These facilities, recognized under the Regulations of Special Medical Techniques and Good Tissue Practice (GTP), support a one-stop turnkey solution, covering everything from equipment planning and facility setup to cell cultivation technology licensing and production operations. We fully meet the clinical and research needs of cell and derivative therapies for diseases and cancer treatment.
Exosome Technology
YJ Biotech leads the way in exosome technology, utilizing advanced research and development for regenerative medicine and anti-aging skincare. Our exosome products are specifically designed to promote effective cell regeneration and improve skin conditions, offering superior safety and stability. These products are versatile and suitable for a wide range of medical and cosmetic applications. By leveraging our proprietary lyophilization (freeze-drying) technology, we ensure the long-term preservation of exosome formulations and their derivative biomedical products, maintaining both their activity and quality. Our freeze-dried formulations can be stored at ambient temperatures, drastically reducing the costs associated with cold chain logistics and lowering carbon emissions, providing a more sustainable solution for global medical product storage and transportation.
Global Expansion and Environmental Commitment
YJ Biotech actively collaborates with medical institutions both domestically and internationally to establish highly efficient, micro-scale cell manufacturing factories that adhere to pharmaceutical safety standards. These facilities are designed to deliver immediate, on-site cell products for clinical applications. Our innovative business model significantly reduces the cold chain logistics required for cell therapy products while also lowering carbon emissions, thereby supporting both environmental sustainability and human health. Beyond advancing cellular pharmaceutical technologies, we are firmly committed to environmental stewardship. Partner with YJ Biotech to revolutionize cell manufacturing and pave the way for a greener, healthier future.
